ReviewFrontiers in immunology2026

JAK inhibitors in rheumatoid arthritis-associated interstitial lung disease: a review of mechanisms and clinical evidence.

Zhiying Wu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.